Incentive boosters to help Indian API industry grow at 7-8% over 3-4 years India imported ₹35,000 crore worth of APIs and bulk drugs in FY22, accounting for 35% of its total API requirement, of which China accounted for 65-70% share. By P B Jayakumar
Will NDA’s landslide victory in Maharashtra election boost market sentiment? Here’s what analysts say
Will NDA’s landslide victory in Maharashtra election boost market sentiment? Here’s what analysts say
